We elucidated mechanisms of TGF-β signaling contributing to EV release from breast cancer (BRCA) and lung adenocarcinoma (LUAD) cells, providing also insight into the protein composition of these EVs and their functional relevance as facilitators of oncogenic transformation. The gene discussed is TGFB1; the disease is lung adenocarcinoma.